Annual ROA
-358.75%
-127.27%-54.98%
01 December 2023
Summary:
TransCode Therapeutics annual return on assets is currently -358.75%, with the most recent change of -127.27% (-54.98%) on 01 December 2023. During the last 3 years, it has fallen by -328.92% (-1102.65%). RNAZ annual ROA is now -1102.65% below its all-time high of -29.83%, reached on 31 December 2021.RNAZ ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-281.35%
-21.03%-8.08%
01 September 2024
Summary:
TransCode Therapeutics quarterly return on assets is currently -281.35%, with the most recent change of -21.03% (-8.08%) on 01 September 2024. Over the past year, it has dropped by -5.26% (-1.91%). RNAZ quarterly ROA is now -728.72% below its all-time high of -33.95%, reached on 31 March 2022.RNAZ Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -1.9% |
3 y3 years | -1102.7% | -422.8% |
5 y5 years | -20.8% | - |
RNAZ ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -1102.7% | at low | -728.7% | at low |
5 y | 5 years | -1102.7% | at low | -728.7% | +56.6% |
alltime | all time | -1102.7% | at low | -728.7% | +56.6% |
TransCode Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -281.35%(+8.1%) |
June 2024 | - | -260.32%(+9.0%) |
Mar 2024 | - | -238.80%(-13.5%) |
Dec 2023 | -358.75%(+55.0%) | -276.09%(+3.2%) |
Sept 2023 | - | -267.59%(+11.9%) |
June 2023 | - | -239.19%(+24.4%) |
Mar 2023 | - | -192.24%(+43.9%) |
Dec 2022 | -231.48% | -133.55%(+49.0%) |
Sept 2022 | - | -89.64%(+37.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | -65.29%(+92.3%) |
Mar 2022 | - | -33.95%(-36.9%) |
Dec 2021 | -29.83%(-86.6%) | -53.82%(-19.5%) |
Sept 2021 | - | -66.89%(-79.3%) |
June 2021 | - | -322.72%(-50.2%) |
Mar 2021 | - | -648.41%(+192.0%) |
Dec 2020 | -222.09%(-25.2%) | - |
Dec 2020 | - | -222.09% |
Dec 2019 | -296.92% | - |
FAQ
- What is TransCode Therapeutics annual return on assets?
- What is the all time high annual ROA for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly ROA year-on-year change?
What is TransCode Therapeutics annual return on assets?
The current annual ROA of RNAZ is -358.75%
What is the all time high annual ROA for TransCode Therapeutics?
TransCode Therapeutics all-time high annual return on assets is -29.83%
What is TransCode Therapeutics quarterly return on assets?
The current quarterly ROA of RNAZ is -281.35%
What is the all time high quarterly ROA for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly return on assets is -33.95%
What is TransCode Therapeutics quarterly ROA year-on-year change?
Over the past year, RNAZ quarterly return on assets has changed by -5.26% (-1.91%)